Omnicell (OMCL) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.42% |
| Dec 31, 2025 | -16.56% |
| Sep 30, 2025 | -22.13% |
| Jun 30, 2025 | 24.46% |
| Mar 31, 2025 | 30.03% |
| Dec 31, 2024 | 23.75% |
| Sep 30, 2024 | 32.97% |
| Jun 30, 2024 | 44.79% |
| Mar 31, 2024 | 46.00% |
| Dec 31, 2023 | 47.43% |
| Sep 30, 2023 | 58.85% |
| Jun 30, 2023 | 53.97% |
| Mar 31, 2023 | 50.72% |
| Dec 31, 2022 | 59.08% |
| Sep 30, 2022 | 104.40% |
| Jun 30, 2022 | 55.51% |
| Mar 31, 2022 | 41.72% |
| Dec 31, 2021 | 44.98% |
| Sep 30, 2021 | 59.07% |
| Jun 30, 2021 | 71.81% |
| Mar 31, 2021 | 59.26% |
| Dec 31, 2020 | 42.67% |
| Sep 30, 2020 | 61.23% |
| Jun 30, 2020 | 8.70% |
| Mar 31, 2020 | -5.70% |
| Dec 31, 2019 | 0.21% |
| Sep 30, 2019 | 5.67% |
| Jun 30, 2019 | -7.09% |
| Mar 31, 2019 | -6.41% |
| Dec 31, 2018 | -8.46% |
| Sep 30, 2018 | -17.59% |
| Jun 30, 2018 | -11.97% |
| Mar 31, 2018 | -8.91% |
| Dec 31, 2017 | -12.25% |
| Sep 30, 2017 | -32.88% |
| Jun 30, 2017 | -13.01% |
| Mar 31, 2017 | -25.46% |
| Dec 31, 2016 | -22.25% |
| Sep 30, 2016 | -23.40% |
| Jun 30, 2016 | -25.71% |
| Dec 31, 2015 | -14.08% |
| Sep 30, 2015 | -20.21% |
| Jun 30, 2015 | -13.82% |